The global drug industry has fought to prevent developing nations from making low-cost, generic versions of drugs under patent, but the demand for such alternatives is could rise with increasing heal…

Some analysts say healthcare costs hinder U.S. industry competitiveness in the global marketplace, but it’s unclear whether proposed health reforms will offer any cost relief.

The Gulf of Mexico oil spill spotlights the growth of deepwater drilling and the challenges of balancing strong environmental regulation with efforts to expand U.S. domestic oil production.

The handoff of foreign policy responsibility from one U.S. presidential administration to another has proven risky in many cases. The next transition occurs at a time of extraordinary global challeng…

China has grown into a trading giant, but recent concerns over the safety of Chinese food and drugs have increased worries that China’s production may have outpaced the country’s policing capacity.